Intrapleural Urokinase for Retained Hemothorax

NCT01134237 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Retained Hemothorax

Interventions

DRUG: urokinase
DRUG: placebo

Sponsor

National Taiwan University Hospital